Esperion Therapeutics, Inc.
ESPR
$3.78
$0.123.28%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 92.45M | 86.06M | 114.63M | 144.76M | 144.72M |
| Total Receivables | 118.98M | 107.75M | 81.29M | 80.14M | 67.82M |
| Inventory | 141.84M | 114.47M | 99.32M | 94.49M | 80.10M |
| Prepaid Expenses | 7.20M | 34.32M | 23.53M | 18.60M | 14.91M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 360.46M | 342.60M | 318.78M | 338.00M | 307.56M |
|
|
|||||
| Total Current Assets | 360.46M | 342.60M | 318.78M | 338.00M | 307.56M |
| Net Property, Plant & Equipment | 3.50M | 4.43M | 5.20M | 5.77M | 6.50M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 56.00K | 56.00K | 56.00K | 56.00K | 56.00K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 364.02M | 347.09M | 324.03M | 343.82M | 314.11M |
|
|
|||||
| Total Accounts Payable | 77.51M | 74.70M | 71.99M | 51.65M | 34.86M |
| Total Accrued Expenses | 20.26M | 16.66M | 23.70M | 24.63M | 22.79M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 152.07M | 123.82M | 114.73M | 104.90M | 41.14M |
| Total Finance Division Other Current Liabilities | 109.19M | 83.61M | 60.55M | 65.05M | 67.08M |
| Total Other Current Liabilities | 109.19M | 83.61M | 60.55M | 65.05M | 67.08M |
| Total Current Liabilities | 359.03M | 298.80M | 270.97M | 246.23M | 165.87M |
|
|
|||||
| Total Current Liabilities | 359.03M | 298.80M | 270.97M | 246.23M | 165.87M |
| Long-Term Debt | 448.15M | 473.05M | 477.30M | 483.74M | 515.15M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 767.00K | 1.31M | 1.97M | 2.57M | 3.30M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 7.44M | 7.44M | -- | -- | -- |
| Total Liabilities | 815.38M | 780.59M | 750.24M | 732.54M | 684.32M |
|
|
|||||
| Common Stock & APIC | 1.29B | 1.28B | 1.27B | 1.27B | 1.26B |
| Retained Earnings | -1.69B | -1.65B | -1.64B | -1.60B | -1.58B |
| Treasury Stock & Other | -55.00M | -55.00M | -55.00M | -55.00M | -55.00M |
| Total Common Equity | -451.36M | -433.51M | -426.21M | -388.72M | -370.21M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -451.36M | -433.51M | -426.21M | -388.72M | -370.21M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -451.36M | -433.51M | -426.21M | -388.72M | -370.21M |
|
|
|||||